Hollings Renton - Net Worth and Insider Trading

Hollings Renton Net Worth

The estimated net worth of Hollings Renton is at least $792,766 dollars as of 2024-04-28. Hollings Renton is the Director of Cepheid and owns about 9,517 shares of Cepheid (CPHD) stock worth over $503,925. Hollings Renton is also the Director of Portola Pharmaceuticals Inc and owns about 16,020 shares of Portola Pharmaceuticals Inc (PTLA) stock worth over $288,841. Details can be seen in Hollings Renton's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Hollings Renton has not made any transactions after 2019-11-01 and currently still holds the listed stock(s).

Transaction Summary of Hollings Renton

To

Hollings Renton Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Hollings Renton owns 6 companies in total, including Portola Pharmaceuticals Inc (PTLA) , Zymeworks Inc (ZYME) , and AnaptysBio Inc (ANAB) among others .

Click here to see the complete history of Hollings Renton’s form 4 insider trades.

Insider Ownership Summary of Hollings Renton

Ticker Comapny Transaction Date Type of Owner
PTLA Portola Pharmaceuticals Inc 2020-07-02 director
ZYME Zymeworks Inc 2022-12-21 director
ANAB AnaptysBio Inc 2017-01-25 director
CPHD Cepheid 2016-11-04 director
RIGL Rigel Pharmaceuticals Inc 2004-01-12 director
AFFY Affymax Inc 2012-06-13 director

Hollings Renton Latest Holdings Summary

Hollings Renton currently owns a total of 2 stocks. Among these stocks, Hollings Renton owns 9,517 shares of Cepheid (CPHD) as of November 7, 2014, with a value of $503,925 and a weighting of 63.57%. Hollings Renton also owns 16,020 shares of Portola Pharmaceuticals Inc (PTLA) as of November 1, 2019, with a value of $288,841 and a weighting of 36.43%.

Latest Holdings of Hollings Renton

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CPHD Cepheid 2014-11-07 9,517 52.95 503,925
PTLA Portola Pharmaceuticals Inc 2019-11-01 16,020 18.03 288,841

Holding Weightings of Hollings Renton


Hollings Renton Form 4 Trading Tracker

According to the SEC Form 4 filings, Hollings Renton has made a total of 0 transactions in Cepheid (CPHD) over the past 5 years. The most-recent trade in Cepheid is the sale of 9,375 shares on November 7, 2014, which brought Hollings Renton around $478,781.

According to the SEC Form 4 filings, Hollings Renton has made a total of 2 transactions in Portola Pharmaceuticals Inc (PTLA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Portola Pharmaceuticals Inc is the sale of 5,000 shares on November 1, 2019, which brought Hollings Renton around $150,000.

Insider Trading History of Hollings Renton

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Hollings Renton Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Hollings Renton Ownership Network

Ownership Network List of Hollings Renton

No Data

Ownership Network Relation of Hollings Renton


Hollings Renton Owned Company Details

What does Portola Pharmaceuticals Inc do?

Who are the key executives at Portola Pharmaceuticals Inc?

Hollings Renton is the director of Portola Pharmaceuticals Inc. Other key executives at Portola Pharmaceuticals Inc include EVP & General Counsel John B Moriarty , EVP and CFO Mardi Dier , and EVP & CMO Rajiv Patni .

Portola Pharmaceuticals Inc (PTLA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Portola Pharmaceuticals Inc (PTLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Portola Pharmaceuticals Inc (PTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Portola Pharmaceuticals Inc (PTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Portola Pharmaceuticals Inc Insider Transactions

No Available Data

Hollings Renton Mailing Address

Above is the net worth, insider trading, and ownership report for Hollings Renton. Currently GuruFocus does not have mailing address information for Hollings Renton.

Discussions on Hollings Renton

No discussions yet.